Funding Details
- Awarder
- Inbox
- Date Award
- January 09, 2025
- Vertical
- Genetic Medicines
- Funding URL
- View Funding Page
- Funding Amount:
-
$33,000,000
Company Info
- Traction
- Coave plans to move two development candidates to CTA/IND-enabling studies in 2026.
- Company Description
- Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.
- Market
- Healthcare
- Location
-
Paris,
France
- Coinvestors
- Novo Holdings A/S, Bpifrance, Invus, UI Investissement, Seroba Life Sciences, Fund+, Kurma Partners, Omnes Capital, Turenne Capital
Links